Skip to content
value.today
Sera Prognostics, Inc. logo

Sera Prognostics, Inc.

SERA
$82 Mmarket cap on Oct 30, 2026-54.2% since Jan 2024
Compare
World rank
#19,475
Revenue
$0 M
For year ending December-2025
Net income
$-32 M
-39912.5% margin
SEC filing
Employees
72
As of December 31, 2025
SEC filing

Sera Prognostics, Inc. in brief

Sera Prognostics, Inc. is a listed company in the Diagnostics and Research industry, based in Salt Lake City, Utah, USA. It was founded in 2008. Its market value was $82 M on 30 October 2026, which makes it the 19,475th largest listed company in the world and the 3,626th largest in the USA on this site. In the year to December 2025 it had sales of $0 M and a net loss of $32 M. It employs about 72 people and Zhenya Lindgardt is its chief executive. Its shares trade under the symbol SERA (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Sera Prognostics, Inc.

We are a women’s health company utilizing our proprietary proteomics and bioinformatics platform, and significant data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. Our vision is to become the global leader in high-value women’s health diagnostics. We plan to do this by taking a holistic approach to providing pivotal and actionable information to pregnant women, their physicians, and health care payers to significantly enhance a mother’s pregnancy journey, improve maternal and neonatal health, and reduce health care costs. We believe that our method of combining the disciplines of proteomics and bioinformatics with rigorous clinical testing, data, and economic analysis enables us to provide physicians and expectant mothers with personally insightful, clinically meaningful, and economically impactful information designed to improve the pregnancy experience and outcomes for mothers and babies.

From the company's annual report filed with the US SEC: read the report

Sera Prognostics, Inc. timeline

4 events, 2008–2023
  1. 2008
  2. 🏁
    · approximate
    Founded
  3. 2011
  4. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  5. 2021
  6. 🔔
    Initial public offering on Nasdaq
    Final prospectus filed with the SEC on 16 July 2021; shares registered for exchange trading on 14 July 2021.
  7. 2023
  8. 💰
    Record revenue of $0 million
    FY2023, the highest of the 6 years on record.

Events of Sera Prognostics, Inc. from the company record, SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$58 M$116 M$174 M$232 M2023202420252026

World rank over time

▼ down 1,118 places since 2022
2022-01-07: #18428#18,42820222022-12-25: #25156#25,15620222023-07-30: #22359#22,35920232024-01-05: #18486#18,48620242026-03-08: #10387#10,38720262026-08-01: #18170#18,17020262026-09-22: #19504#19,50420262026-10-30: #19546#19,5462026

Rank in USA: #3,775 (Jan 2022) · #4,774 (Dec 2022) · #4,332 (Jul 2023) · #3,333 (Jan 2024) · #2,026 (Mar 2026) · #3,568 (Aug 2026) · #3,631 (Sep 2026) · #3,629 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
1024.1×
Price / book
1.1×
Free cash flow yield
-32.2%
Net margin (TTM)
-41837.5%
Operating margin
-45625.0%
Return on equity
-44.4%
Liabilities / assets
26.0%
Revenue growth
0.0%
R&D / revenue
16462.5%
Revenue per employee
$1 K
Profit per employee
$-443 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2020: revenue $0M, net income $-20M$0MFY20Fiscal year ending Dec 2021: revenue $0M, net income $-35M$0MFY21Fiscal year ending Dec 2022: revenue $0M, net income $-44M$0MFY22Fiscal year ending Dec 2023: revenue $0M, net income $-36M$0MFY23Fiscal year ending Dec 2024: revenue $0M, net income $-33M$0MFY24Fiscal year ending Dec 2025: revenue $0M, net income $-32M$0MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$0M0.0%$-37M$-32M-39912.5%
Dec 2024$0M-74.2%$-37M$-33M-41125.0%
Dec 2023$0M+14.8%$-40M$-36M-11690.3%
Dec 2022$0M+237.5%$-46M$-44M-16366.7%
Dec 2021$0M+300.0%$-35M$-35M-43762.5%
Dec 2020$0M—$-18M$-20M-99250.0%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-26M$1M$-26M$-0.67—
Dec 2024$-14M$0M$-14M$-0.99—
Dec 2023$-27M$0M$-27M$-1.16—
Dec 2022$-35M$1M$-35M$-1.43—
Dec 2021$-32M$1M$-33M$-2.33—
Dec 2020$-17M$0M$-17M$-12.76—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$0M
Net income, trailing 12 months
$-33M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue —, net income $-9M—Dec ’24Three months to Mar 2025: revenue $0M, net income $-8M$0MMar ’25Three months to Jun 2025: revenue $0M, net income $-8M$0MJun ’25Three months to Sep 2025: revenue $0M, net income $-8M$0MSep ’25Three months to Dec 2025 (from the annual report): revenue $0M, net income $-8M$0MDec ’25Three months to Mar 2026: revenue $0M, net income $-8M$0MMar ’26Three months to Jun 2026: revenue $0M, net income $-9M$0MJun ’26Three months to Sep 2026: revenue $0M, net income $-8M$0MSep ’26

Latest quarter to Sep 2026: revenue $0M (+100.0% on a year earlier), net income $-8M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

SEC filings

Official filings of Sera Prognostics, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$0 M
Operating income
$-37 M
Net income
$-32 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$102 M
Total liabilities
$27 M
Total equity
$75 M

As of December-2025

Top 48 institutional investors in Sera Prognostics, Inc.#

As of Sep 30, 2026
48 institutions held 19.7 M shares (about 49.0% of the shares outstanding) on Sep 30, 2026. The ten largest hold 45.4%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Sera Prognostics, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Baker Bros. Advisors LP5,498,1700 (0.00%)13.63%$11 MNov 16, 2026
2Whetstone Capital Advisors, LLC3,306,8890 (0.00%)8.20%$7 MNov 16, 2026
3Aberdeen Group plc2,953,194+199,669 (+7.25%)7.32%$6 MNov 10, 2026
4PSP Research LLC2,396,685New5.94%$5 MOct 21, 2026
5Vivo Capital, LLC1,650,4400 (0.00%)4.09%$3 MNov 13, 2026
6Vanguard Capital Management LLC1,297,7920 (0.00%)3.22%$3 MNov 13, 2026
7Geode Capital Management, LLC348,9670 (0.00%)0.87%$1 MNov 6, 2026
8Sanders Morris Harris LLC314,950New0.78%$1 MOct 14, 2026
9Captrust Financial Advisors306,863-228,892 (-42.72%)0.76%$1 MNov 12, 2026
10BlackRock, Inc.223,374+2,005 (+0.91%)0.55%$0 MNov 13, 2026
11Vanguard Fiduciary Trust Co208,249+37,341 (+21.85%)0.52%$0 MNov 13, 2026
12AWM Investment Company, Inc.207,3820 (0.00%)0.51%$0 MNov 13, 2026
13State Street Corp124,7920 (0.00%)0.31%$0 MNov 12, 2026
14Perigon Wealth Management, LLC72,6850 (0.00%)0.18%$0 MOct 22, 2026
15Northern Trust Corp68,5950 (0.00%)0.17%$0 MNov 16, 2026
16Millennium Management LLC61,949-12,037 (-16.27%)0.15%$0 MNov 16, 2026
17Bank of New York Mellon Corp60,9270 (0.00%)0.15%$0 MNov 5, 2026
18Requisite Capital Management, LLC55,6480 (0.00%)0.14%$0 MNov 12, 2026
19Bridgeway Capital Management, LLC54,856-849 (-1.52%)0.14%$0 MNov 16, 2026
20Citadel Advisors LLC50,271+8,860 (+21.40%)0.12%$0 MNov 16, 2026
21Empowered Funds, LLC50,256New0.12%$0 MNov 13, 2026
22Ballentine Partners, LLC49,6640 (0.00%)0.12%$0 MNov 13, 2026
23Morgan Stanley48,572-2,400 (-4.71%)0.12%$0 MNov 13, 2026
24Goldman Sachs Group Inc47,974+15,433 (+47.43%)0.12%$0 MNov 16, 2026
25Twelve Points Wealth Management LLC43,3880 (0.00%)0.11%$0 MNov 3, 2026

All 48 institutional investors: 26 to 48, with who bought and sold →

Mutual funds holding Sera Prognostics, Inc.#

19 funds hold shares worth $8 M (about 12.7% of the company). Since their previous reports 12 added shares and 3 sold, buying $1 M net.
Mutual funds holding Sera Prognostics, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 abrdn Healthcare Investorsabrdn Inc.1.38 M$3 M3.9%0.18%+6.3%Jun 30, 2026
🇺🇸 abrdn Healthcare Opportunities Fundabrdn Inc.1.36 M$2 M3.8%0.30%+8.0%Jun 30, 2026
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.887,016$2 M2.5%<0.01%no changeJun 30, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.380,212$1 M1.1%<0.01%+25%Jun 30, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC172,649$0 M0.48%<0.01%+7.6%May 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors102,359$0 M0.29%0.01%+29%Jun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC50,639$0 M0.14%<0.01%no changeMay 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC43,469$0 M0.12%<0.01%+3.2%May 31, 2026
🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC51,105$0 M0.14%0.06%+24%Jun 30, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC23,191$0 M0.07%<0.01%no changeMay 31, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.21,836$0 M0.06%<0.01%+109%Jun 30, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.18,716$0 M0.05%<0.01%newJun 30, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.11,848$0 M0.03%<0.01%no changeJun 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC6,968$0 M0.02%<0.01%+30%Jun 30, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust5,403$0 M0.02%<0.01%no changeMay 31, 2026
🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP5,101$0 M0.01%<0.01%newJul 31, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC3,288$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc.2,450$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC174$0 M<0.01%<0.01%+11%Jul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 19 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Sera Prognostics, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$531 K
44 sales, 10 insiders
Net, 12 months
-$531 K
open market only
Insiders on file
24
since
-$1.6 M$0Dec 2023: bought $0 (0 trades), sold $76 K (2 trades)Dec 23Feb 2024: bought $0 (0 trades), sold $389 K (6 trades)Mar 2024: bought $0 (0 trades), sold $1.6 M (12 trades)May 2024: bought $0 (0 trades), sold $351 K (7 trades)Jun 2024: bought $0 (0 trades), sold $262 K (2 trades)JunAug 2024: bought $0 (0 trades), sold $212 K (7 trades)Sep 2024: bought $0 (0 trades), sold $229 K (3 trades)Oct 2024: bought $0 (0 trades), sold $686 (1 trades)Nov 2024: bought $0 (0 trades), sold $206 K (7 trades)NovDec 2024: bought $0 (0 trades), sold $237 K (3 trades)Jan 2025: bought $0 (0 trades), sold $671 K (27 trades)Feb 2025: bought $0 (0 trades), sold $195 K (9 trades)Mar 2025: bought $0 (0 trades), sold $198 K (9 trades)MarApr 2025: bought $0 (0 trades), sold $358 (1 trades)May 2025: bought $0 (0 trades), sold $102 K (7 trades)Jun 2025: bought $0 (0 trades), sold $54 K (9 trades)Jul 2025: bought $0 (0 trades), sold $552 (1 trades)JulAug 2025: bought $0 (0 trades), sold $153 K (9 trades)Sep 2025: bought $0 (0 trades), sold $133 K (12 trades)Oct 2025: bought $0 (0 trades), sold $7 K (2 trades)Nov 2025: bought $0 (0 trades), sold $135 K (9 trades)NovDec 2025: bought $0 (0 trades), sold $244 K (13 trades)Jan 2026: bought $0 (0 trades), sold $6 K (1 trades)Feb 2026: bought $0 (0 trades), sold $5 K (1 trades)Mar 2026: bought $0 (0 trades), sold $99 K (14 trades)MarJun 2026: bought $0 (0 trades), sold $91 K (8 trades)Sep 2026: bought $0 (0 trades), sold $63 K (5 trades)Oct 2026: bought $0 (0 trades), sold $16 K (1 trades)
Bought (open market)Sold (open market)Hover a month for the totals
Sera Prognostics, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Inglis Tiffany Eul DavisChief Medical OfficerSell-8,024$2.030$16 K83,565Form 4
filed Inglis Tiffany Eul DavisChief Medical OfficerSell-486$2.000$97291,589Form 4
filed Zhenya LindgardtChief Executive Officer, DirectorSell-7,022$2.000$14 K837,848Form 4
filed Benjamin JacksonGeneral CounselSell-2,190$2.000$4 K159,566Form 4
filed Dyaarl Lee Anderson Jr.Chief Commercial OfficerSell-1,800$2.000$4 K76,198Form 4
filed Zhenya LindgardtChief Executive Officer, DirectorSell-20,139$2.000$40 K844,870Form 4
filed Scott GleasonChief Financial OfficerGrant or award+117,924——117,924Form 4
filed Joshua PhillipsDirectorGrant or award+22,426——79,431Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Sera Prognostics, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
219,751
9.12 days to cover
Shares sold short, last 24 reportsAll stocks →

Stock splits: 1-for-2.08 reverse split

Fails to deliver

  • : 90 shares at $2.06
  • : 1 shares at $2.04
  • : 1 shares at $2.03
  • : 505 shares at $2.12
  • : 66 shares at $1.99

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Sera Prognostics, Inc. scorecard#

Passes 2 of the 14 checks that could be worked out: strongest in financial health (1 of 3), weakest in growth (0 of 3). Fiscal year 2025; market cap of Oct 30, 2026.

  • Valuation1 of 4
  • Growth0 of 3
  • Profitability0 of 3
  • Financial health1 of 3
  • Shareholder returns0 of 1

Worked out from the statements as filed (sec), the medians of Diagnostics and Research, the 10-year Treasury yield of Nov 20, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Sera Prognostics, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Sera Prognostics, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020
Income statement
Revenue0.10.10.30.30.10.0
Cost of revenue0.20.10.2———
Research and development13151514117.8
Selling and marketing6.55.88.315103.6
General and administrative17161617146.6
Operating expenses373740463518
Operating income−37−37−40−46−35−18
Interest expense and finance costs0.00.00.1———
Other non-operating income (expense)4.63.83.61.51.1−0.0
Income before tax−32−33————
Income tax000000
Net income attributable to shareholders−32−33−36−44−35−20
Earnings per share, basic-0.67-0.99-1.16-1.43-2.33-12.76
Earnings per share, diluted-0.67-0.99-1.16-1.43-2.33-12.76
Shares, weighted average (basic)48333131151.6
Shares, weighted average (diluted)48333131151.6
Balance sheet
Cash and cash equivalents3.94.03.9305914
Short-term investments35424553460
Receivables0.00.00.20.10.00.0
Other current assets1.61.3r0.81.32.00.2
Current assets4148619011014
Property, plant and equipment1.11.22.03.11.81.0
Right-of-use (leased) assets2.40.61.21.7——
Other intangible assets0.91.00———
Total assets102739511614715
Accounts payable0.92.01.01.51.20.4
Current liabilities242524168.411
Lease liabilities (non-current)2.300.61.20—
Total liabilities272525178.512
Retained earnings−312−280−247−211−166−131
Shareholders' equity75487099139−126
Total liabilities and equity102739511614715
Cash-flow statement
Depreciation and amortization0.90.80.90.80.70.9
Share-based compensation5.17.05.35.13.10.7
Cash from operating activities−26−14−27−35−32−17
Capital expenditure−0.7−0.1−0.1−0.8−1.3−0.1
Intangible assets bought0−1.00———
Cash from investing activities−29120.45.6−83−0.1
Debt issued————01.1
Debt repaid———0−3.10
Shares issued54—————
Cash from financing activities542.60.80.01609.2
Report10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Events at Sera Prognostics, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Directors and officers 3 · Material agreement 1 · Shareholder vote 3 · Results announced 12

Sera Prognostics, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Directors and officers8-K
Results announced8-K
Directors and officers8-K
Shareholder vote8-K
Directors and officers8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Results announced8-K
Material agreement8-K
Results announced8-K
Results announced8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 4, 2026

Acquisitions and funding#

6 private funding rounds before listing

Private share sales · funding history

Private share sales of Sera Prognostics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2021$100 MNo. 6$50 to $250 million16equity, debt, optionsSEC
Jul 2019$52 MNo. 5$50 to $250 million28equity, debt, optionsSEC
Jan 2017$23 MNo. 4$10 to $50 million5equitySEC
Nov 2014$5 MNo. 3$2 to $10 million15equitySEC
May 2014$9 MNo. 2$2 to $10 million15equitySEC
Nov 2011$10 MNo. 1$10 to $50 million15equitySEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its annual reports since 2010, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

How Sera Prognostics, Inc. compares in Diagnostics and Research

  • Market cap$82 M · higher than 25% of 110
  • Revenue$0 M · higher than 2% of 123
  • Revenue growth0.0% · higher than 31% of 89
  • Price / book1.1× · lower than 82% of 84
  • FCF yield-32.2% · higher than 15% of 66

Peer comparison · Diagnostics and Research

CompanyMarket capP/ENet marginRev. growth
Sera Prognostics, Inc.🇺🇸$82 M——0.0%
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%
Danaher Corporation🇺🇸$166.7 B38.5×16.9%+2.9%
WuXi AppTec Co., Ltd.🇨🇳$70.4 B25.4×42.1%—
Natera, Inc.🇺🇸$58.7 B—-5.7%+35.9%
Siemens Healthineers AG🇩🇪$52.8 B22.9×8.7%—
Lonza Group AG🇨🇭$51.9 B—-4.2%—
Agilent Technologies, Inc.🇺🇸$48.8 B33.9×19.5%+6.7%
IQVIA Holdings Inc.🇺🇸$45.1 B32.4×8.1%+5.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 30, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As of December 31, 2025
Profile updated:
Nov 21, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Sera Prognostics, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Sera Prognostics, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Sera Prognostics, Inc.? Suggest a correction